Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction

Transplantation

Volumn 64, Issue 6, 1997, Pages 795-800

  Vella, John P ^a   Spadafora Ferreira, Monica ^a   Murphy, Barbara ^a   Alexander, Stephen I ^a   Harmon, William ^a   Carpenter, Charles B ^a   Sayegh, Mohamed H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ADULT; ARTICLE; CADAVER; CELL PROLIFERATION; CHILD; CLINICAL FEATURE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEINURIA; T LYMPHOCYTE;

ADULT; AMINO ACID SEQUENCE; CELLS, CULTURED; COCULTURE TECHNIQUES; CREATININE; DNA; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

EID: 0030879985     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199709270-00001     Document Type: Article

References (32)

1. Kahan BD. Drug therapy: cyclosporine. N Engl J Med 1989; 321(25): 1725.
2. Cecka JM, Terasaki PI. The UNOS scientific renal transplant registry. In: Terasaki PI, ed. Clinical transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1995: 1.
3. Carpenter CB. Long term failure of renal transplants: adding insult to injury. Kidney Int 1995; 48: S40.
4. Hostetter TH. Chronic transplant rejection. Kidney Int 1994; 46: 266.
5. Paul LC. Chronic renal transplant loss. Kidney Int 1995; 47(6): 1491.
6. Pirsch JD, D'Alessandro AM, Sollinger HW, et al. The effect of donor age, recipient age, and HLA match on immunologic graft survival in cadaver renal transplant recipients. Transplantation 1992; 53(1): 55.
7. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
8. Matas AJ, Gillingham KJ, Payne WD, et al. The impact of an acute rejection episode on long-term renal allograft survival. Transplantation 1994; 57: 857.
9. Tullius SG, Tilney NL. Both alloantigen dependent and independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313.
10. Shoskes AD, Wood JK. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15(1): 2.
11. Sayegh MH, Watschinger B, Carpenter CB. Mechanisms of T cell recognition of alloantigen: the role of peptides. Transplantation 1994; 57: 1295.
12. Sherman AL, Chattopadhyay S. The molecular basis of allorecognition. Annu Rev Immunol 1993; 11: 385.
13. Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992; 175(6): 1521.
14. Auchincloss HJ, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci U S A 1993; 90(8): 3373.
15. Watschinger B, Gallon L, Carpenter CB, Sayegh MH. Mechanisms of allo-recognition: recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 1994; 57(4): 572.
16. Gallon L, Watschinger B, Murphy B, Akalin E, Sayegh MH, Carpenter CB. The indirect pathway of allorecognition: the occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression. Transplantation 1995; 59(4): 612.
17. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 1996; 93(24): 13967.
18. Mach F, Schonbeck U, Sukhova GK, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 1997; 94(5): 1931.
19. Hollenbaugh D, Mischel PN, Edwards CP, et al. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995; 182(1): 33.
20. Marelli BF, Hargreaves RE, Carmichael P, Dorling A, Lombardi G, Lechler RI. Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells. J Exp Med 1996; 183(4): 1603.
21. Sayegh MH, Carpenter CB. Role of indirect allorecognition in allograft rejection. Int Rev Immunol 1996; 13: 221.
22. Liu Z, Sun YK, Xi YP, et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 1993; 177(6): 1643.
23. Steele DJ, Laufer TM, Smiley ST, et al. Two levels of help for B cell alloantibody production. J Exp Med 1996; 183(2): 699.
24. Fukaura H, Kent S, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β-1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996; 98: 70.
25. Fey K, Melchers I, Eichmann K. Quantitative studies on T cell diversity: IV. Mathematical analysis of multiple limiting populations of effector and suppressor T cells. J Exp Med 1983; 158(1): 40.
26. Liu Z, Colovai AI, Tugulea S, et al. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 1996; 98(5): 1150.
27. Muluk SC, Clerici M, Via CS, Weir MR, Kimmel PL, Shearer GM. Correlation of in vitro CD4+ T helper cell function with clinical graft status immunosuppressed kidney transplant recipients. Transplantation 1991; 52: 284.
28. Schulik RD, Weir MR, Miller MW, Cohen DJ, Bermas BL, Shearer GM. Longitudinal study of in vitro CD4+ T helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs. Transplantation 1993; 56: 590.
29. Saleem M, Gustafsson K, Fabre JW. Attempts to demonstrate indirect T cell allorecognition of donor MHC peptides in transplant patients. Immunol Lett 1996; 54(1): 21.
30. Sawyer GJ, Dalchau R, Fabre JW. Indirect T cell allorecognition: a cyclosporin A resistant pathway for T cell help for antibody production to donor MHC antigens. Transpl Immunol 1993; 1(1): 77.
31. Clerici M, Shearer GM. Differential sensitivity of human T helper cell pathways by in vitro exposure to cyclosporin A. J Immunol 1990; 144(7): 2480.
32. Liu Z, Harris PE, Colovai AI, Reed EF, Maffei A, Suciu FN. Indirect recognition of donor MHC class II antigens in human transplantation. Clin Immunol Immunopathol 1996; 78(3): 228.